Monthly Archives: February 2017

Cantor Fitzgerald Believes SUPN Still Has Room to Grow

468767.jpg

In a report released yesterday, William Tanner from Cantor Fitzgerald reiterated a Buy rating on Supernus Pharmaceuticals (NASDAQ: SUPN), with a price target of $31. The company’s shares closed yesterday at $25.70, close to its 52-week high of $27.95. Tanner

Analysts’ Opinions Are Mixed on These Financial Stocks: JP Morgan Chase (NYSE: JPM) and Arch Capital Group Ltd (NASDAQ: ACGL)

468765.png

Analysts have been eager to weigh in on the Financial sector with new ratings on JP Morgan Chase (NYSE: JPM) and Arch Capital Group Ltd (NASDAQ: ACGL). JP Morgan Chase (NYSE: JPM) BMO Capital analyst James Fotheringham reiterated a Hold

Why did Oppenheimer Downgrade Cirrus Logic’s Stock?

468763.gif

Cirrus Logic (NASDAQ: CRUS) received a Hold rating from Oppenheimer analyst Rick Schafer yesterday. The company’s shares closed yesterday at $54.08. Schafer wrote: “We are downgrading shares of CRUS to Perform and removing our $70 target. Our CY17 estimates are

Canaccord Genuity Believes AMZN Won’t Stop Here

468761.jpg

Canaccord Genuity analyst Michael Graham reiterated a Buy rating on Amazon (NASDAQ: AMZN) yesterday and set a price target of $900. The company’s shares closed yesterday at $845.04, close to its 52-week high of $860.86. According to TipRanks.com, Graham is

Canaccord Genuity Believes GOOGL Still Has Room to Grow

468759.jpg

In a report released yesterday, Michael Graham from Canaccord Genuity reiterated a Buy rating on Alphabet Inc (NASDAQ: GOOGL), with a price target of $950. The company’s shares closed yesterday at $844.93, close to its 52-week high of $867. According

Canaccord Genuity Reiterates a Hold Rating on Endo International

468757.jpg

In a report released yesterday, Dewey Steadman from Canaccord Genuity reiterated a Hold rating on Endo International (NASDAQ: ENDP), with a price target of $14. The company’s shares closed yesterday at $13.65, close to its 52-week low of $11.37. According